Suppr超能文献

通过C3b/C4b受体(CR1,CD35)和膜辅因子蛋白(MCP,CD46)对经典途径中人补体C4b进行I因子依赖性失活。

Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).

作者信息

Masaki T, Matsumoto M, Nakanishi I, Yasuda R, Seya T

机构信息

Department of Immunology, Center for Adult Diseases Osaka.

出版信息

J Biochem. 1992 May;111(5):573-8. doi: 10.1093/oxfordjournals.jbchem.a123799.

Abstract

Proteolytic inactivation of C4b is a crucial step for regulation of the classical complement pathway. A plasma protease factor I and membrane cofactors, C3b/C4b receptor (CR1) and membrane cofactor protein (MCP), participate in the regulation of cell-bound C4b although the physiological potency of these cofactors remains unknown. We have examined the optimal conditions of the factor I-mediated C4b regulatory system using purified cofactors. CR1 being a cofactor at a cofactor/C4b ratio less than 0.1 (w/w), fluid phase C4b, and methylamine-treated C4 (C4ma) were degraded by factor I into C4bi: minimal Cd4 was generated in the fluid phase. Liposome-bound C4b (LAC4b), on the other hand, was degraded into C4c and C4d. CR1 showed two optimal pHs (6.0 and 7.5) for fluid phase C4b, but one (6.0) for LAC4b, and in both cases low conductivity conditions enhanced the C4bi generation. CR1 cofactor activity was barely influenced by the NP-40 concentration. On the other hand, MCP degraded C4b and C4ma, as a factor I-cofactor, more efficiently into C4c and C4d. Though MCP cofactor activity, like that of CR1, was enhanced under low conductivity conditions, it has only one optimal pH, 6.0, in both fluid and solid phases. Furthermore, as in the case of C3b cleavage, a sufficient NP-40 concentration to solubilize membrane was needed for MCP to express full cofactor activity for C4b, in contrast to CR1. MCP was less potent for C4b inactivation than for C3b inactivation, while CR1 acted as a slightly more effective cofactor for C4b cleavage than for C3b cleavage.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

C4b的蛋白水解失活是经典补体途径调控的关键步骤。血浆蛋白酶因子I和膜辅因子,即C3b/C4b受体(CR1)和膜辅因子蛋白(MCP),参与细胞结合型C4b的调控,尽管这些辅因子的生理效能尚不清楚。我们使用纯化的辅因子研究了因子I介导的C4b调节系统的最佳条件。当辅因子/C4b比例小于0.1(w/w)时,CR1作为辅因子,液相C4b和甲胺处理的C4(C4ma)被因子I降解为C4bi:液相中产生的最小C4d。另一方面,脂质体结合的C4b(LAC4b)被降解为C4c和C4d。CR1对液相C4b显示出两个最佳pH值(6.0和7.5),对LAC4b则为一个(6.0),在这两种情况下,低电导率条件均增强了C4bi的产生。CR1的辅因子活性几乎不受NP - 40浓度的影响。另一方面,MCP作为因子I的辅因子,将C4b和C4ma更有效地降解为C4c和C4d。尽管MCP的辅因子活性与CR1一样,在低电导率条件下增强,但在液相和固相中它只有一个最佳pH值,即6.0。此外,与CR1不同,对于MCP而言,需要足够浓度的NP - 40来溶解膜,以表达其对C4b的完全辅因子活性。MCP对C4b失活的效力低于对C3b失活的效力,而CR1作为C4b裂解的辅因子比作为C3b裂解的辅因子稍更有效。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验